T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLOC
2276
Flowco Holdings
FLOC
$811M
| $736K | ﹤0.01% |
35,722
+2,866
| +9% | +$62.1K |
|
|
GOLD
2277
Gold.com Inc
GOLD
$1.16B
| $734K | ﹤0.01% |
18,311
+2,539
| +16% | +$124K |
|
2278
Kearny Financial
KRNY
$604M
| $729K | ﹤0.01% |
96,507
| – | – |
|
2279
Scansource
SCSC
$1.17B
| $729K | ﹤0.01% |
20,066
+3,960
| +25% | +$151K |
|
2280
Alpha and Omega Semiconductor
AOSL
$829M
| $728K | ﹤0.01% |
32,823
+4,965
| +18% | +$108K |
|
2281
Monro
MNRO
$414M
| $727K | ﹤0.01% |
45,274
+540
| +1% | +$10.5K |
|
2282
Byline Bancorp
BY
$1.78B
| $726K | ﹤0.01% |
22,969
+4,780
| +26% | +$150K |
|
2283
Matrix Service
MTRX
$312M
| $726K | ﹤0.01% |
63,191
+9,979
| +19% | +$119K |
|
2284
NVE Corp
NVEC
$543M
| $726K | ﹤0.01% |
11,076
+1,786
| +19% | +$120K |
|
2285
OneSpan
OSPN
$584M
| $722K | ﹤0.01% |
68,501
+11,482
| +20% | +$130K |
|
|
NNE
2286
Nano Nuclear Energy
NNE
$799M
| $718K | ﹤0.01% |
35,033
+7,290
| +26% | +$199K |
|
2287
Peapack-Gladstone Financial
PGC
$815M
| $716K | ﹤0.01% |
20,325
+1,887
| +10% | +$61.4K |
|
|
BDN
2288
Brandywine Realty Trust
BDN
$509M
| $715K | ﹤0.01% |
263,575
+59,025
| +29% | +$177K |
|
2289
First Community Bankshares
FCBC
$899M
| $713K | ﹤0.01% |
17,170
-579
| -3% | -$22.1K |
|
2290
Mitek Systems
MITK
$756M
| $712K | ﹤0.01% |
52,700
+7,439
| +16% | +$92K |
|
2291
Taysha Gene Therapies
TSHA
$1.61B
| $711K | ﹤0.01% |
158,954
+37,140
| +30% | +$173K |
|
2292
B&G Foods
BGS
$303M
| $710K | ﹤0.01% |
147,569
+33,490
| +29% | +$162K |
|
2293
Clover Health Investments
CLOV
$2.23B
| $710K | ﹤0.01% |
402,901
+67,377
| +20% | +$146K |
|
2294
Dine Brands
DIN
$462M
| $708K | ﹤0.01% |
26,956
+1,399
| +5% | +$45.4K |
|
2295
Genius Sports
GENI
$1.95B
| $707K | ﹤0.01% |
159,498
+32,095
| +25% | +$228K |
|
|
ESPR
2296
DELISTED
Esperion Therapeutics
ESPR
| $706K | ﹤0.01% |
257,427
+68,788
| +36% | +$218K |
|
|
NFBK
2297
DELISTED
Northfield Bancorp
NFBK
| $706K | ﹤0.01% |
52,138
+3,248
| +7% | +$41.9K |
|
|
PSTL
2298
Postal Realty Trust
PSTL
$703M
| $706K | ﹤0.01% |
38,020
-1,480
| -4% | -$27.4K |
|
2299
MBIA
MBI
$275M
| $703K | ﹤0.01% |
118,855
+12,250
| +11% | +$78K |
|
|
ANL
2300
Adlai Nortye
ANL
$780M
| $691K | ﹤0.01% |
+99,843
| New | +$667K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.